Shield Therapeutics
Manufacturing · Switzerland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Sihleggstrasse 23, Wollerau, Schwyz, 883...Phone Number
+41 435080781Website
www.shieldtherapeutics.comRevenue
$16.6 MillionStock Symbol
STX.LIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Shield Therapeutics
Shield is a de-risked, commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients' unmet medical needs. The Company's clear purpose is to help its patients become people again, by enabling them to enjoy the things that make the difference in their everyday lives. The Group has a marketed product, Feraccru®, for the treatment of iron deficiency in adults which has exclusive IP rights until the mid-2030s. Feraccru® is commercialised in the European Union by Norgine BV and the US Food and Drug Administration (FDA) is currently considering a New Drug Application (NDA), with a PDUFA (Prescription Drug User Fee Act) date of 27th July 2019.Explore more
Shield Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Shield Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Shield Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Shield Therapeutics
Shield Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Shield Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Shield Therapeutics launches new products
Click to see if Shield Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Shield Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Shield Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Shield Therapeutics
Find more new buyers
Company Profile Activity
Activity Insights
Shield Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Shield Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Shield Therapeutics.
Shield Therapeutics financials insights
Gather financial insights about Shield Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Series A
$8.2M
2022
Debt
$10M
2024
Share Placement
$10M
Shield Therapeutics Tech Stack
A closer look at the technologies used by Shield Therapeutics
See more technologies
Most Recent Scoops
Open Position
Open Position
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Open Position
Funding
Funding
Shield Therapeutics News & Media
Shield shares jump after FDA extends Accrufer exclusivity
Broker Cavendish says additional US protection strengthens long-term outlook and reiterates buy rating. Shares in Shield Therapeutics PLC (AIM:STX, OTCQB:SHIEF) jumped as much 11% earlier in the session after the company said US regulators had granted an additional three years of data...When Will Shield Therapeutics plc (LON:STX) Breakeven?
We feel now is a pretty good time to analyse Shield Therapeutics plc's ( LON:STX ) business as it appears the company...Amends Senior Secured Debt Financing | Company Announcement - Investegate
Investegate announcements from Amends Senior Secured Debt Financing
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Shield Therapeutics
Sign Up For FreeTo access detailed company insights
Shield is a de-risked, commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients' unmet medical needs. The Company's clear purpose is to help its patients become people again, by enabling them to enjoy the things that make the difference in their everyday lives. The Group has a marketed product, Fe... Read More
